Metabolic improvement with short-term, glucagon-like peptide-1 receptor agonist treatment does not improve cardiac diastolic dysfunction in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial

Annemie Stege Bojer, Martin Heyn Sørensen, Jenny Bjerre, Peter Gaede, Niels Vejlstrup, Per Lav Madsen

Fingeraftryk

Dyk ned i forskningsemnerne om 'Metabolic improvement with short-term, glucagon-like peptide-1 receptor agonist treatment does not improve cardiac diastolic dysfunction in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial'. Sammen danner de et unikt fingeraftryk.

Keyphrases

Medicine and Dentistry